Biological Research
Pathways, mechanisms, biological targets and research questions.
ORIGINA / Science
The scientific engine
of ORIGINA.
Research · Formulation · Clinical Science · IP · Manufacturing Development
01 · Institutional function
An R&D organization,
not a label.
ORIGINA Labs represents an institutional research and development function — translating biological questions into evidence, prototypes, technical files, and repeatable methods.
Every breakthrough formula, proprietary platform, evaluation protocol, and manufacturing pathway begins here under direct scientific direction.
02 · Capabilities
Seven connected capabilities.
An institutional R&D architecture — closer to a research organization than a cosmetics page.
Formulation Science
Translate biological hypotheses into stable, manufacturable formulations.
Analytical Development
Develop appropriate approaches for characterizing formulations and relevant actives.
Safety & Quality
Evaluate quality, stability and safety according to product category and risk.
Clinical Evaluation
Design or support appropriate human evaluation where scientifically and regulatorily appropriate.
Intellectual Property
Document formulations, inventions, systems, processes, technologies and platforms for appropriate protection.
Manufacturing Translation
Translate validated laboratory concepts into repeatable manufacturing.
03 · Continuum
From question to repeatable output.
Five connected stages within the broader development framework.
Define the unmet human or scientific need.
Build evidence, hypotheses, and design criteria.
Translate knowledge into a viable intervention.
Test performance, safety, and suitability.
Prepare a controlled path to manufacturing.
04 · Horizon
Skin science is
the beginning.
The Labs framework expands when excellence can be sustained — subject to scientific feasibility and institutional capacity.
DermatologyRegenerative technologiesPersonal careMedical devicesNutritional scienceFields yet to emerge
05 · Knowledge archive
Research in active development.
A living index of questions, protocols, and evidence streams. Public briefs are released as work reaches appropriate disclosure standards — not before.
Foundational programmeActive
BMelanox™ formulation platform
Investigating a disciplined product system for visible uneven tone and melanin-rich skin.
Research questionScoping
Contextual drivers of uneven pigmentation
Mapping environmental, behavioural, and biological variables to improve how formulation questions are framed.
ProtocolDevelopment
Barrier-first evaluation framework
Building a repeatable approach to evaluating tolerance and suitability without separating efficacy from skin-barrier health.
MethodsActive
From formulation logic to controlled scale
Documenting the decisions required to protect formula intent as laboratory work moves toward manufacturing.